FDA Finalizes Guidance to Help CMS With Coverage Decisions on Devices
By Zachary Brennan -
Published 04 December 2017
The US Food and Drug Administration (FDA) on Monday finalized guidance meant to assist the Centers for Medicare and Medicaid Services (CMS) in determining whether or not an investigational device should be reimbursed by CMS.
Categories: News, US, FDA, Medical Devices, Regulatory intelligence, Regulatory strategy, Submission and registration
Tags: CMS coverage of medical devices, FDA guidance